Global News | World latest News| Trending News
Newswise — Boston – Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine. The vaccines were administered after surgery to remove…
Newswise — PHILADELPHIA – Susan M. Domchek, MD, FASCO, has been recognized by the American Society of Clinical Oncology (ASCO) with one of the society’s highest honors, as the 2025 recipient of the ASCO-American Cancer Society Cancer Prevention Award. Domchek is the Basser Professor in Oncology in the Perelman School of Medicine at the University of Pennsylvania, and executive…
Abstract Newswise — Background: Various studies have reported on the impact of human papillomavirus (HPV) vaccines. Here we present the largest population-based investigation of genotype-specific distributions over the decade following implementation of the 4-valent HPV vaccine (HPV6/11/16/18) in the United States. Methods: Liquid-based cervical cytology samples from individuals aged 15-30 years undergoing cervical screening throughout…
COVID-19 positivity rates are down since November, says the Saskatchewan Health Authority’s Community Respiratory Illness Surveillance Program report, but so are immunizations.
Newswise — LOS ANGELES — The human papillomavirus (HPV), a common sexually transmitted infection, accounts for 70% of all throat cancers, according to the National Cancer Institute. While commonly associated with cervical cancer, throat cancer is now the most common type of HPV-related cancer. However, the majority of American adults are unaware that HPV can…
